Brenus Pharma vs Crossbow Therapeutics
Brenus Pharma vs Crossbow Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Brenus Pharma is on 48/100 and Crossbow Therapeutics on 55/100.
Where each one leads
Brenus Pharma
Leads on none of the measures we hold for both companies.
Crossbow Therapeutics
- our overall score: 55/100 against 48/100
- agent readiness: 45/100 against 36/100
- headcount: 40 against 29
- funding raised: $157M against $12.6M
At a glance
| Measure | Brenus Pharma | Crossbow Therapeutics |
|---|---|---|
| What it is | Clinical-stage immunotherapy company developing novel treatments for cancer. | Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Cancer, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | Not published | 2021 |
| Headquarters | Lyon, France | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Brenus Pharma | Crossbow Therapeutics |
|---|---|---|
| Employees | 29 | 40 |
| Total funding | $12.6M | $157M |
| Latest round | Series A | Series B |
| LinkedIn followers | 6,500 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Brenus Pharma | Crossbow Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 55/100 |
| Traction | 50/100 | 56/100 |
| Team | Not published | 70/100 |
| Search visibility | 31/100 | 15/100 |
| Quality | 62/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | Not published | 25/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Brenus Pharma | Crossbow Therapeutics |
|---|---|---|
| CMS | Not detected | Wix |
| Open source | No | Yes |
Brenus Pharma vs Crossbow Therapeutics: common questions
Which is better, Brenus Pharma or Crossbow Therapeutics?
On our 0-100 score Crossbow Therapeutics rates higher (55/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Brenus Pharma and Crossbow Therapeutics compare on the numbers?
Crossbow Therapeutics leads on our overall score (55/100 against 48/100), agent readiness (45/100 against 36/100), headcount (40 against 29), funding raised ($157M against $12.6M).
Read the full Brenus Pharma review and pricing or the Crossbow Therapeutics review and pricing. You can also browse other Brenus Pharma alternatives we track.